Jan 10, 2020 / 01:00PM GMT
Operator
Good morning, and welcome to the Moderna CMV 7-month Interim Data Conference Call. (Operator Instructions) Please be advised that the call is being recorded.
At this time, I'd like to turn the call over to Lavina Talukdar, Head of Investor Relations at Moderna. Please proceed.
Lavina Talukdar - Moderna, Inc. - Head of IR
Thank you, Shannon. Good morning and happy new year, everyone. At today's conference call, we will review 7-month interim data from the company's Phase I CMV vaccine program. You can access the press release issued yesterday as well as the slides that we'll be reviewing by going to the Investors section of our website.
Speaking on the call today will be Stéphane Bancel, Chief Executive Officer; and Tal Zaks, Chief Medical Officer. Also present in the room is Lorence Kim, Chief Financial Officer.
Before we begin, I would like to remind you that this conference call will include forward-looking statements. Please see Slide 2 of the accompanying presentation and our SEC filings for important factors that could cause
Moderna Inc CMV Interim Data Conference Call Transcript
Jan 10, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers